WPA
Winning Points Advisors’s Cytosorbents Corp CTSO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-22,900
| Closed | -$33K | – | 46 |
|
2022
Q3 | $33K | Sell |
22,900
-2,000
| -8% | -$2.88K | 0.04% | 47 |
|
2022
Q2 | $54K | Sell |
24,900
-43,500
| -64% | -$94.3K | 0.06% | 52 |
|
2022
Q1 | $218K | Buy |
+68,400
| New | +$218K | 0.17% | 53 |
|
2021
Q4 | – | Sell |
-86,200
| Closed | -$701K | – | 71 |
|
2021
Q3 | $701K | Sell |
86,200
-50,700
| -37% | -$412K | 0.51% | 38 |
|
2021
Q2 | $1.04M | Sell |
136,900
-2,200
| -2% | -$16.6K | 0.78% | 30 |
|
2021
Q1 | $1.2M | Hold |
139,100
| – | – | 0.9% | 29 |
|
2020
Q4 | $1.11M | Sell |
139,100
-4,000
| -3% | -$32K | 0.89% | 28 |
|
2020
Q3 | $1.14M | Buy |
143,100
+86,600
| +153% | +$691K | 0.97% | 26 |
|
2020
Q2 | $559K | Buy |
56,500
+21,500
| +61% | +$213K | 0.53% | 35 |
|
2020
Q1 | $269K | Buy |
35,000
+5,000
| +17% | +$38.4K | 0.26% | 47 |
|
2019
Q4 | $115K | Buy |
+30,000
| New | +$115K | 0.07% | 74 |
|